Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer
作者： Christine M Lovly , Nerina T McDonald , Heidi Chen , Sandra Ortiz-Cuaran , Lukas C Heukamp
DOI: 10.1038/NM.3667
关键词:
摘要: Crizotinib, a selective tyrosine kinase inhibitor (TKI), shows marked activity in patients whose lung cancers harbor fusions in the gene encoding anaplastic lymphoma receptor tyrosine …
elsevier.com
utsystem.edu
nature.com参考文章(32)
Alice T. Shaw, Dong-Wan Kim, Ranee Mehra, Daniel S.W. Tan, Enriqueta Felip, Laura Q.M. Chow, D. Ross Camidge, Johan Vansteenkiste, Sunil Sharma, Tommaso De Pas, Gregory J. Riely, Benjamin J. Solomon, Juergen Wolf, Michael Thomas, Martin Schuler, Geoffrey Liu, Armando Santoro, Yvonne Y. Lau, Meredith Goldwasser, Anthony L. Boral, Jeffrey A. Engelman, Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 370, pp. 1189- 1197 ,(2014) , 10.1056/NEJMOA1311107
G. Iyer, A. J. Hanrahan, M. I. Milowsky, H. Al-Ahmadie, S. N. Scott, M. Janakiraman, M. Pirun, C. Sander, N. D. Socci, I. Ostrovnaya, A. Viale, A. Heguy, L. Peng, T. A. Chan, B. Bochner, D. F. Bajorin, M. F. Berger, B. S. Taylor, D. B. Solit, Genome Sequencing Identifies a Basis for Everolimus Sensitivity Science. ,vol. 338, pp. 221- 221 ,(2012) , 10.1126/SCIENCE.1226344
Carlos Garcı́a-Echeverrı́a, Mark A Pearson, Andreas Marti, Thomas Meyer, Juergen Mestan, Johann Zimmermann, Jiaping Gao, Josef Brueggen, Hans-Georg Capraro, Robert Cozens, Dean B Evans, Doriano Fabbro, Pascal Furet, Diana Graus Porta, Janis Liebetanz, Georg Martiny-Baron, Stephan Ruetz, Francesco Hofmann, In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase Cancer Cell. ,vol. 5, pp. 231- 239 ,(2004) , 10.1016/S1535-6108(04)00051-0
A. V. Galkin, J. S. Melnick, S. Kim, T. L. Hood, N. Li, L. Li, G. Xia, R. Steensma, G. Chopiuk, J. Jiang, Y. Wan, P. Ding, Y. Liu, F. Sun, P. G. Schultz, N. S. Gray, M. Warmuth, Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 270- 275 ,(2007) , 10.1073/PNAS.0609412103
Christine M. Lovly, Johannes M. Heuckmann, Elisa de Stanchina, Heidi Chen, Roman K. Thomas, Chris Liang, William Pao, Insights into ALK-Driven Cancers Revealed through Development of Novel ALK Tyrosine Kinase Inhibitors Cancer Research. ,vol. 71, pp. 4920- 4931 ,(2011) , 10.1158/0008-5472.CAN-10-3879
Alexis B. Cortot, Claire E. Repellin, Takeshi Shimamura, Marzia Capelletti, Kreshnik Zejnullahu, Dalia Ercan, James G. Christensen, Kwok-Kin Wong, Nathanael S. Gray, Pasi A. Jänne, Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway Cancer Research. ,vol. 73, pp. 834- 843 ,(2013) , 10.1158/0008-5472.CAN-12-2066
Zengliu Su, Dora Dias-Santagata, MarKeesa Duke, Katherine Hutchinson, Ya-Lun Lin, Darrell R. Borger, Christine H. Chung, Pierre P. Massion, Cindy L. Vnencak-Jones, A. John Iafrate, William Pao, A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer The Journal of Molecular Diagnostics. ,vol. 13, pp. 74- 84 ,(2011) , 10.1016/J.JMOLDX.2010.11.010
S. Morris, M. Kirstein, M. Valentine, K. Dittmer, D. Shapiro, D. Saltman, A. Look, Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma Science. ,vol. 263, pp. 1281- 1284 ,(1994) , 10.1126/SCIENCE.8122112
Alejandro Vazquez-Martin, Sílvia Cufí, Cristina Oliveras-Ferraros, Violeta Zenobia Torres-Garcia, Bruna Corominas-Faja, Elisabet Cuyàs, Rosa Bonavia, Joana Visa, Begoña Martin-Castillo, Enrique Barrajón-Catalán, Vicente Micol, Joaquim Bosch-Barrera, Javier A. Menendez, IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations Scientific Reports. ,vol. 3, pp. 2560- 2560 ,(2013) , 10.1038/SREP02560
Robert C. Doebele, Amanda B. Pilling, Dara L. Aisner, Tatiana G. Kutateladze, Anh T. Le, Andrew J. Weickhardt, Kimi L. Kondo, Derek J. Linderman, Lynn E. Heasley, Wilbur A. Franklin, Marileila Varella-Garcia, D. Ross Camidge, Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer Clinical Cancer Research. ,vol. 18, pp. 1472- 1482 ,(2012) , 10.1158/1078-0432.CCR-11-2906